Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor κB pathway

Food and Chemical Toxicology

Volumn 45, Issue 7, 2007, Pages 1249-1257

  Hsu, Ya Ling ^a   Kuo, Po Lin ^a   Cho, Chien Yu ^b   Ni, Wen Chiu ^a   Tzeng, Tz Fei ^b   Ng, Lean Teik ^c   Kuo, Yueh Hsiung ^d   Lin, Chun Ching ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TAJEN UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Antrodia cinnamomea; Invasion; Liver cancer; MMPs; NF B

Indexed keywords

ACETIC ACID ETHYL ESTER; ANTRODIA CINNAMOMEA EXTRACT; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MATRIX METALLOPROTEINASE 14; NATURAL PRODUCT; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTRODIA CINNAMOMEA; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CONTROLLED STUDY; DRUG DNA BINDING; FRUITING BODY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE;

ACETATES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FRUITING BODIES, FUNGAL; HUMANS; LIVER NEOPLASMS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; PLANT EXTRACTS; POLYPORALES; SOLVENTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANTRODIA CINNAMOMEA; MUS MUSCULUS;

EID: 34247163539     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.01.005     Document Type: Article

References (44)

1. Aggarwal B.B. Nuclear factor-kappa B: the enemy within. Cancer Cell 6 (2004) 203-208
2. Chang T.T., and Chou W.N. Antrodia cinnamomea reconsidered and A. salmomed sp. Nov. on Cunninghamia konishii in Taiwan. Bot. Bull. Acad. Sin. 45 (2004) 347-352
3. Chirco R., Liu X.W., Jung K.K., and Kim H.R. Novel functions of TIMPs in cell signaling. Cancer Metast. Rev. 25 (2006) 99-113
4. Christofori G. New signals from the invasive front. Nature 441 (2006) 444-450
5. Chung T.W., Moon S.K., Chang Y.C., Ko J.H., Lee Y.C., Cho G., Kim S.H., Kim J.G., and Kim C.H. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 18 (2004) 1670-1681
6. Denoyelle C., Vasse M., Korner M., Mishal Z., Ganne F., Vannier J.P., Soria J., and Soria C. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis 22 (2001) 1139-1148
7. Deryugina E.I., and Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metast. Rev. 25 (2006) 9-34
8. Dixit V., and Mak T.W. NF-kappaB signaling. Many roads lead to Madrid. Cell 111 (2002) 615-619
9. Herr I., and Debatin K.M. Cellular stress response and apoptosis in cancer therapy. Blood 98 (2001) 2603-2614
10. Hofmann U.B., Houben R., Brocker E.B., and Becker J.C. Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87 (2005) 307-314
11. Hou L., Li Y., Jia Y.H., Wang B., Xin Y., Ling M.Y., and Lu S. Molecular mechanism about lymphogenous metastasis of hepatocarcinoma cells in mice. World J. Gastroenterol. 7 (2001) 532-536
12. Hsiao G., Shen M.L., Lin K.H., Lan M.H., Wu L.Y., Chou D.S., Lin C.H., Su C.H., and Sheu J.R. Antioxidative and hepatoprotective effects of Antrodia camphorata extract. J. Agric. Food Chem. 51 (2003) 3302-3308
13. Hsu Y.L., Kuo P.L., Lin L.T., and Lin C.C. Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J. Pharmacol. Exp. Ther. 313 (2005) 333-344
14. Hsu Y.L., Kuo Y.C., Kuo P.L., Ng L.T., Kuo Y.H., and Lin C.C. Apoptotic effects of extract from Antrodia camphorata fruiting bodies in human hepatocellular carcinoma cell lines. Cancer Lett. 221 (2005) 77-89
15. Hsu Y.L., Cho C.Y., Kuo P.L., Huang Y.T., and Lin C.C. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. J. Pharmacol. Exp. Ther. 318 (2006) 484-494
16. Huang S.M., Li J., and Harari P.M. Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade. Mol. Cancer Ther. 1 (2002) 507-514
17. Huang G.W., Yang L.Y., and Lu W.Q. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival. World J. Gastroenterol. 11 (2005) 1705-1708
18. Huang S.C., Ho C.T., Lin-Shiau S.Y., and Lin J.K. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun. Biochem. Pharmacol. 69 (2005) 221-232
19. Ikenaka Y., Yoshiji H., Kuriyama S., Yoshii J., Noguchi R., Tsujinoue H., Yanase K., Namisaki T., Imazu H., Masaki T., and Fukui H. Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int. J. Cancer 105 (2003) 340-346
20. Karin M., Cao M.Y., Greten F.R., and Li Z.W. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
21. Ko C.H., Shen S.C., Lee T.J., and Chen Y.C. Myricetin inhibits matrix metalloproteinase 2 protein expression and enzyme activity in colorectal carcinoma cells. Mol. Cancer Ther. 4 (2005) 281-290
22. Kuo P.L., Hsu Y.L., Cho C.Y., Ng L.T., Kuo Y.H., and Lin C.C. Apoptotic effects of Antrodia cinnamomea fruiting bodies extract are mediated through calcium and calpain-dependent pathways in Hep 3B cells. Food Chem. Toxicol. 44 (2006) 1316-1326
23. Lee I.H., Huang R.L., Chen C.T., Chen H.C., Hsu W.C., and Lu M.K. Antrodia camphorata polysaccharides exhibit anti-hepatitis B virus effects. FEMS Microbiol. Lett. 209 (2002) 63-67
24. Liu J.J., Huang T.S., Hsu M.L., Chen C.C., Lin W.S., Lu F.J., and Chang W.H. Antitumor effects of the partially purified polysaccharides from Antrodia camphorata and the mechanism of its action. Toxicol. Appl. Pharmacol. 201 (2004) 186-193
25. Liu L.Z., Fang J., Zhou Q., Hu X., Shi X., and Jiang B.H. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Mol. Pharmacol. (2005) 635-643
26. Marrero J.A. Hepatocellular carcinoma. Curr. Opin. Gastroenterol. 22 (2006) 248-253
27. Motola-Kuba D., Zamora-Valdes D., Uribe M., and Mendez-Sanchez N. Hepatocellular carcinoma. An overview. Ann. Hepatol. 5 (2006) 16-24
28. Munshi A., Kurland J.F., Nishikawa T., Chiao P.J., Andreeff M., and Meyn R.E. Inhibition of constitutively activated nuclear factor-kappaB radio sensitizes human melanoma cells. Mol. Cancer Ther. 3 (2004) 985-992
29. Nakamura N., Hirakawa A., Gao J.J., Kakuda H., Shiro M., Komatsu Y., Sheu C.C., and Hattori M. Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J. Nat. Prod. 67 (2004) 46-48
30. Pan S.L., Guh J.H., Peng C.Y., Wang S.W., Chang Y.L., Cheng F.C., Chang J.H., Kuo S.C., Lee F.Y., and Teng C.M. YC-1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole] inhibits endothelial cell functions induced by angiogenic factors in vitro and angiogenesis in vivo models. J. Pharmacol. Exp. Ther. 314 (2005) 35-42
31. Park H.J., Chung H.J., Min H.Y., Park E.J., Hong J.Y., Kim W.B., Kim S.H., and Lee S.K. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases. Biochem. Pharmacol. 71 (2005) 21-31
32. Qin L.X., and Tang Z.Y. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J. Cancer Res. Clin. Oncol. 130 (2004) 497-513
33. Rao J.S., Gondi C., Chetty C., Chittivelu S., Joseph P.A., and Lakka S.S. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol. Cancer Ther. 4 (2005) 1399-1408
34. Ross P.J., George M., Cunningham D., DiStefano F., Andreyev H.J., Workman P., and Clarke P.A. Inhibition of Kirsten-ras expression in human colorectal cancer using rationally selected Kirsten-ras antisense oligonucleotides. Mol. Cancer Ther. 1 (2001) 29-41
35. Shen Y.C., Wang Y.H., Chou Y.C., Chen C.F., Lin L.C., Chang T.T., Tien J.H., and Chou C.J. Evaluation of the Anti-Inflammatory Activity of Zhankuic Acids Isolated from the Fruiting Bodies of Antrodia camphorata. Planta Med. 70 (2004) 310-314
36. Shishodia S., Gutierrez A.M., Lotan R., and Aggarwal B.B. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products. Cancer Res. 65 (2005) 9555-9565
37. Song T.Y., and Yen G.C. Antioxidant properties of Antrodia camphorata in submerged culture. J. Agric. Food Chem. 50 (2002) 3322-3327
38. Srivastava S.K., and Singh S.V. Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 25 (2004) 1701-1709
39. Turlin B., Le Quilleuc D., Leroyer P., Brissot P., Deugnier Y., and Loreal O. High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice. J. Hepatol. 37 (2002) 620-624
40. Vosseler S., Mirancea N., Bohlen P., Mueller M.M., and Fusenig N.E. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res. 65 (2005) 1294-1305
41. 2+)-NO-cGMP pathway. Life Sci. 73 (2003) 2769-2783
42. Woodworth C.D., Michael E., Marker D., Allen S., Smith L., and Nees M. Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol. Cancer Ther. 4 (2005) 650-658
43. Zhang A., Meng L., Wang Q., Xi L., Chen G., Wang S., Zhou J., Lu Y., and Ma D. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2. Oncol. Rep. 15 (2006) 831-836
44. Zucker S., Cao J., and Chen W.T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 19 (2000) 6642-6650